AllianceBernstein’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $102K | Hold |
|
|||||
|
2023
Q4 | $55.2K | Sell |
|
|||||
|
2023
Q3 | $73.4K | Sell |
|
|||||
|
2023
Q2 | $190K | Buy |
|
|||||
|
2023
Q1 | $256K | Buy |
|
|||||
|
2022
Q4 | $299K | Buy |
|
|||||
|
2022
Q3 | $505K | Hold |
|
|||||
|
2022
Q2 | $495K | Buy |
|
|||||
|
2022
Q1 | $422K | Sell |
|
|||||
|
2021
Q4 | $524K | Sell |
|
|||||
|
2021
Q3 | $1.5M | Buy |
|
|||||
|
2021
Q2 | $716K | Buy |
|
|||||
|
2021
Q1 | $718K | Sell |
|
|||||
|
2020
Q4 | $903K | Sell |
|
|||||
|
2020
Q3 | $496K | Sell |
|
|||||
|
2020
Q2 | $642K | Buy |
|
|||||
|
2020
Q1 | $329K | Buy |
|
|||||
|
2019
Q4 | $272K | Buy |
|
|||||
|
2019
Q3 | $181K | Buy |
|